ZentMed Co., Ltd.
Your Current Location: Home - News Center - Clinical Studies -
Guideline | Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma Carcinoma
2025-11-19
Share:

Abstract

Globally, the incidence and associated mortality of primary liver cancer have been steadily increasing. Currently,80% of cases are found in Asia.Curative resection is applicable in only 20% of patients; therefore, various nonsurgical treatment modalities have been developed. Image-guided per-cutaneous liver tumor ablation is regarded as the best option for treating early-stage hepatocellular carcinoma(HCC). However, skills and knowledge in ablation can vary among operators. Furthermore, Asia has the highest number of ablation procedures for HCC and the largest number of doctors performing ablation worldwide. Thus,the Asian Conference on Tumor Ablation has developed guidelines for HCC. These guidelines will discuss indications, pre-ablative diagnosis and planning, techniques, peri-ablative management, evaluation of therapeutic effectiveness,complications, post-ablative follow-up, prevention of recurrence, and treatment of recurrence for HCC.


Keywords

Hepatocellular carcinoma, Ablation, Guidelines


Article


Disclaimer: If there are any copyright issues, please contact us and we will contact you and delete the content as soon as possible.
Copyright © ZentMed Co., Ltd. All Rights Reserved Bomin
Download the Full Article
Full Name *
Tel *
E-mail *
Organization Name *
City *
Country/Region *
Information *
*Required field